← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

CFO Howard Horn sold $228K of Ultragenyx Pharmaceutical Inc.

Sold$227,538
$22.65Price
10,044Shares
−11%Stake

What RARE did after the filing

Filed Mar 3Copier in Mar 4
The stock from Wed, Mar 4 open, $22.07
+11.1%
S&P 500, same days
+2.9%

Measured over 30 trading days, to the Apr 16 close.

Traded Mon, Mar 2. Filed Tue, Mar 3, 6:50 PM ET, after the close. Returns use the Mar 4 open and the Apr 16 close. Not investment advice.